2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent

2-Hydroxypropyl-β-cyclodextrin (HP-β-CyD) is a cyclic oligosaccharide that is widely used as an enabling excipient in pharmaceutical formulations, but also as a cholesterol modifier. HP-β-CyD has recently been approved for the treatment of Niemann-Pick Type C disease, a lysosomal lipid storage disor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Yokoo, Masako, Kubota, Yasushi, Motoyama, Keiichi, Higashi, Taishi, Taniyoshi, Masatoshi, Tokumaru, Hiroko, Nishiyama, Rena, Tabe, Yoko, Mochinaga, Sakiko, Sato, Akemi, Sueoka-Aragane, Naoko, Sueoka, Eisaburo, Arima, Hidetoshi, Irie, Tetsumi, Kimura, Shinya
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2015
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633159/
https://ncbi.nlm.nih.gov/pubmed/26535909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141946
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires